| Literature DB >> 25028429 |
David M Engelthaler1, Nathan D Hicks1, John D Gillece1, Chandler C Roe1, James M Schupp1, Elizabeth M Driebe1, Felix Gilgado2, Fabian Carriconde, Luciana Trilles, Carolina Firacative, Popchai Ngamskulrungroj, Elizabeth Castañeda3, Marcia dos Santos Lazera4, Marcia S C Melhem5, Asa Pérez-Bercoff, Gavin Huttley6, Tania C Sorrell2, Kerstin Voelz, Robin C May, Matthew C Fisher7, George R Thompson8, Shawn R Lockhart9, Paul Keim10, Wieland Meyer11.
Abstract
The emergence of distinct populations of Cryptococcus gattii in the temperate North American Pacific Northwest (PNW) was surprising, as this species was previously thought to be confined to tropical and semitropical regions. Beyond a new habitat niche, the dominant emergent population displayed increased virulence and caused primary pulmonary disease, as opposed to the predominantly neurologic disease seen previously elsewhere. Whole-genome sequencing was performed on 118 C. gattii isolates, including the PNW subtypes and the global diversity of molecular type VGII, to better ascertain the natural source and genomic adaptations leading to the emergence of infection in the PNW. Overall, the VGII population was highly diverse, demonstrating large numbers of mutational and recombinational events; however, the three dominant subtypes from the PNW were of low diversity and were completely clonal. Although strains of VGII were found on at least five continents, all genetic subpopulations were represented or were most closely related to strains from South America. The phylogenetic data are consistent with multiple dispersal events from South America to North America and elsewhere. Numerous gene content differences were identified between the emergent clones and other VGII lineages, including genes potentially related to habitat adaptation, virulence, and pathology. Evidence was also found for possible gene introgression from Cryptococcus neoformans var. grubii that is rarely seen in global C. gattii but that was present in all PNW populations. These findings provide greater understanding of C. gattii evolution in North America and support extensive evolution in, and dispersal from, South America. Importance: Cryptococcus gattii emerged in the temperate North American Pacific Northwest (PNW) in the late 1990s. Beyond a new environmental niche, these emergent populations displayed increased virulence and resulted in a different pattern of clinical disease. In particular, severe pulmonary infections predominated in contrast to presentation with neurologic disease as seen previously elsewhere. We employed population-level whole-genome sequencing and analysis to explore the genetic relationships and gene content of the PNW C. gattii populations. We provide evidence that the PNW strains originated from South America and identified numerous genes potentially related to habitat adaptation, virulence expression, and clinical presentation. Characterization of these genetic features may lead to improved diagnostics and therapies for such fungal infections. The data indicate that there were multiple recent introductions of C. gattii into the PNW. Public health vigilance is warranted for emergence in regions where C. gattii is not thought to be endemic.Entities:
Mesh:
Year: 2014 PMID: 25028429 PMCID: PMC4161256 DOI: 10.1128/mBio.01464-14
Source DB: PubMed Journal: mBio Impact factor: 7.867
FIG 1 Phylogenetic analysis of C. gattii isolates representing the major molecular types VGI to VGIV. Maximum-parsimony phylogenetic analysis was performed on WGST SNP data from 35 C. gattii genomes (one each of VGI, VGIII, and VGIV molecular types and 32 genomes representing the diversity of the VGII subtypes). The analysis found 1,282,876 total SNPs with 544,881 of them being parsimonious SNPs, with a consistency index (CI) of 0.729. The tree shown is not rooted. Branch lengths represent numbers of SNPs between taxa, with the unit bar in the figure. Unless otherwise shown in red, all branches had bootstrap values of 100 with 500 generations. The taxon nomenclature includes a unique strain identifier and a two-letter country or state abbreviation for the geographic source of the original isolate (AR, Argentina; AU, Australia; AW, Aruba; BR, Brazil; CO, Colombia; DK, Denmark; GR, Greece; JP, Japan; MY, Malaysia; TH, Thailand; UY, Uruguay; VE, Venezuela; BC, British Columbia, Canada; ZA, South Africa; and for the United States, CA, California; FL, Florida; HI, Hawai’i; ID, Idaho; OR, Oregon; WA, Washington).
FIG 2 Phylogenetic network of C. gattii VGII. A neighbor net representation of the relationships among all VGII subtypes based on WGST SNP data, using the uncorrected p-distance transformation. Each band of parallel edges indicates a split. For example, the two splits that group ST33 with two distinct groups of other VGII subtypes are labeled with red A and B letters. The split joining VGIIc with three additional STs is labeled with a red C letter.
FIG 3 SNP phylogeny from whole genomes from VGIIa isolates. Maximum-parsimony phylogenetic analysis was performed on all isolate genomes within VGIIa. The VGIIa tree includes 717 SNPs (97 parsimony informative) from 17 isolates (CI = 1.0). For country and state abbreviations, see the legend to Fig. 1. Numbers in black on top of branches are SNP length, and numbers in red next to branches are the bootstrap values generated from 500 generations.
FIG 4 SNP phylogeny from whole genomes from VGIIc isolates. Maximum-parsimony phylogenetic analysis was performed on all isolate genomes within VGIIc. The VGIIc tree includes 246 SNPs (55 parsimony informative) from 25 isolates (CI = 1.0). For state abbreviations, see the legend to Fig. 1. Numbers in black on top of branches are SNP length, and numbers in red next to branches are the bootstrap values generated from 500 generations.
FIG 5 SNP phylogeny from whole genomes from VGIIb isolates. Maximum-parsimony phylogenetic analysis was performed on all isolate genomes within VGIIb. The VGIIb tree includes 528 SNPs (147 parsimony informative) from 17 isolates (CI = 1.0). For country or state abbreviations, see the legend to Fig. 1. Numbers in black on top of branches are SNP length, and numbers in red next to branches are the bootstrap values generated from 500 generations.
Cryptococcus gattii and C. neoformans isolates used in this study[]
| Genotype | Strain | ST | Country | Source | Yr of isolation | Figure inclusion |
|---|---|---|---|---|---|---|
| VGI | WM 179 | 51 | Australia | Clinical | 1993 | 1, 6, 7 |
| VGIIa | B6864 | 20 | USA | Clinical | 2004 | 2, 3, S2, S3 |
| B7395 | 20 | USA | Veterinary | 2008 | 2, 3, S2, S3 | |
| B7422 | 20 | USA | Veterinary | 2009 | 2, 3, S2, S3 | |
| B7436 | 20 | USA | Veterinary | 2009 | 2, 3, S2, S3 | |
| B7467 | 20 | USA | Veterinary | 2009 | 2, 3, S2, S3 | |
| B8555 | 20 | USA | Clinical | 2006 | 2, 3, S2, S3 | |
| B8577 | 20 | Canada | Environmental | 2009 | 2, 3, S2, S3 | |
| B8793 | 20 | USA | Veterinary | 2010 | 2, 3, S2, S3 | |
| B8849 | 20 | USA | Environmental | 2010 | 2, 3, S2, S3 | |
| B9457 | 20 | USA | Clinical | 2011 | 2, 3, S2, S3 | |
| B9458 | 20 | USA | Clinical | 2011 | 2, 3, S2, S3 | |
| B9757 | 20 | USA | Environmental | 2002 | 2, 3, S2, S3 | |
| B9759 | 20 | USA | Veterinary | 2003 | 2, 3, S2, S3 | |
| CA-1014 | 20 | USA | Clinical | ? | 2, 3, S2, S3 | |
| CBS 7750 | 20 | USA | Environmental | 1990 | 2, 3, S2, S3 | |
| R265 | 20 | Canada | Clinical | 2001 | 1, 2, 3, 6, 7, S2, S3 | |
| HL_A1 | 20 | Canada | Veterinary | 2002 | 2, 3, S2, S3 | |
| HL_A3 | 20 | Canada | Environmental | 2002 | 2, 3, S2, S3 | |
| HL_A11 | 20 | Canada | Clinical | 2001 | 2, 3, S2, S3 | |
| HL_B5 | 20 | Canada | Clinical | 2002 | 2, 3, S2, S3 | |
| HL_B6 | 20 | Denmark | Clinical | 2006 | 2, 3, S2, S3 | |
| NIH 444 | 20 | USA | Clinical | 1975 | 2, 3, S2, S3 | |
| WM 03.697 | 20 | Canada | Veterinary | 2001 | 2, 3, S2, S3 | |
| WM 05.432 | 20 | Japan-Brazil | Clinical | 2000 | 2, 3, S2, S3 | |
| WM 05.554 | 20 | Brazil | Clinical | 2002 | 2, 3, S2, S3 | |
| WM 06.10 | 20 | Argentina | Clinical | 2000 | 2, 3, S2, S3 | |
| ICB-107 | 252 | Brazil | Clinical | 1981 | 2, 3, S2, S3 | |
| VGIIb | B7394 | 7 | USA | Veterinary | 2008 | 2, 5, S2, S3, S4 |
| B7735 | 7 | USA | Clinical | 2009 | 2, 5, S2, S3, S4 | |
| B8554 | 7 | USA | Veterinary | 2008 | 2, 5, S2, S3, S4 | |
| B8828 | 7 | USA | Veterinary | 2010 | 2, 5, S2, S3, S4 | |
| B9157 | 7 | USA | Veterinary | 2011 | 2, 5, S2, S3, S4 | |
| B9552 | 7 | USA | Veterinary | 2011 | 2, 5, S2, S3, S4 | |
| B9563 | 7 | USA | Veterinary | 2011 | 1, 2, 5, 6, 7, S2, S3, S4 | |
| B9588 | 7 | USA | Clinical | 2012 | 2, 5, S2, S3, S4 | |
| B9758 | 7 | USA | Environmental | 2002 | 2, 5, S2, S3, S4 | |
| CDC R272 | 7 | Canada | Clinical | 2001 | 2, 5, S2, S3, S4 | |
| WM 2552 | 7 | Malaysia | Clinical | 1997 | 2, 5, S2, S3, S4 | |
| WM 03.27 | 7 | Australia | Environmental | 1992 | 2, 5, S2, S3, S4 | |
| WM 04.71 | 7 | Australia | Veterinary | 1991 | 2, 5, S2, S3, S4 | |
| WM 05.465 | 7 | Brazil | Clinical | 1997 | 2, 5, S2, S3, S4 | |
| WM 06.634 | 7 | Thailand | Clinical | 1994 | 2, 5, S2, S3, S4 | |
| WM 06.636 | 7 | Thailand | Clinical | 1995 | 2, 5, S2, S3, S4 | |
| WM 04.75 | 30 | Thailand | Clinical | 1993 | 2, 5, S2, S3, S4 | |
| VGIIc | B6863 | 6 | USA | Clinical | 2005 | 2, 4, S2, S3 |
| B7432 | 6 | USA | Clinical | 2009 | 2, 4, S2, S3 | |
| B7434 | 6 | USA | Clinical | 2008 | 2, 4, S2, S3 | |
| B7466 | 6 | USA | Veterinary | 2008 | 2, 4, S2, S3 | |
| B7491 | 6 | USA | Clinical | 2009 | 2, 4, S2, S3 | |
| B7493 | 6 | USA | Veterinary | 2009 | 2, 4, S2, S3 | |
| B7641 | 6 | USA | Veterinary | 2008 | 2, 4, S2, S3 | |
| B7737 | 6 | USA | Clinical | 2009 | 2, 4, S2, S3 | |
| B7765 | 6 | USA | Veterinary | 2009 | 2, 4, S2, S3 | |
| B8210 | 6 | USA | Clinical | 2008 | 2, 4, S2, S3 | |
| B8214 | 6 | USA | Clinical | 2009 | 2, 4, S2, S3 | |
| B8510 | 6 | USA | Clinical | 2009 | 2, 4, S2, S3 | |
| B8571 | 6 | USA | Clinical | 2009 | 2, 4, S2, S3 | |
| B8788 | 6 | USA | Clinical | 2010 | 2, 4, S2, S3 | |
| B8798 | 6 | USA | Clinical | 2005 | 2, 4, S2, S3 | |
| B8825 | 6 | USA | Clinical | 2010 | 1, 2, 4, S2, S3 | |
| B8833 | 6 | USA | Clinical | 2010 | 2, 4, S2, S3 | |
| B8838 | 6 | USA | Clinical | 2010 | 2, 4, S2, S3 | |
| B8843 | 6 | USA | Clinical | 2010 | 2, 4, S2, S3 | |
| B9816 | 6 | USA | Veterinary | 2012 | 2, 4, S2, S3 | |
| B9933 | 6 | USA | Clinical | 2012 | 2, 4, S2, S3 | |
| GT-11-7650 | 6 | USA | Veterinary | ? | 2, 4, S2, S3 | |
| HL_B3 | 6 | USA | Clinical | 2005 | 2, 4, S2, S3 | |
| HL_B4 | 6 | USA | Clinical | 2008 | 2, 4, S2, S3 | |
| B7390 | 49 | USA | Clinical | 2008 | 2, 4, S2, S3 | |
| VGII | B8973 | 50 | USA | Clinical | 2010 | 1, 2, 6, 7, S2, S3 |
| B9764 | 21 | USA | Veterinary | 2012 | 1, 2, 6, 7, S2, S3 | |
| IAL-3225 | 264 | Brazil | Veterinary | 1994 | 1, 2, 6, 7, S2, S3 | |
| IAL-3234 | 137 | Brazil | Veterinary | 1998 | 1, 2, 6, 7, S2, S3 | |
| IAL-3243 | 283 | Brazil | Veterinary | 2000 | 1, 2, 6, 7, S2, S3 | |
| HL_A2 | 28 | Brazil | Clinical | Pre-2008 | 2, S2, S3 | |
| HL_A4 | 3 | Uruguay | Environmental | 1996 | 1, 2, 6, 7, S2, S3 | |
| HL_A5 | 124 | Brazil | Environmental | Pre-2008 | 1, 2, 6, 7, S2, S3 | |
| HL_A6 | 25 | Aruba | Veterinary | 1953 | 2, S2, S3 | |
| HL_A8 | 185 | Brazil | Environmental | Pre-2008 | 2, S2, S3 | |
| HL_B2 | 248 | Brazil | Veterinary | 2000 | 1, 2, 6, 7, S2, S3 | |
| HL_B11 | 35 | Greece | Clinical | 1996 | 1, 2, 6, 7, S2, S3 | |
| HL_B12 | 18 | Greece | Clinical | 1998 | 2, S2, S3 | |
| WM 178 | 21 | Australia | Clinical | 1991 | 2, S2, S3 | |
| WM 1850 | 25 | Venezuela | Clinical | 1999 | 2, S2, S3 | |
| WM 1851 | 45 | Venezuela | Clinical | 1999 | 1, 2, 6, 7, S2, S3 | |
| WM 3032 | 33 | Australia | Clinical | 1983 | 1, 2, 6, 7, S2, S3 | |
| WM 04.78 | 31 | Colombia | Clinical | 1998 | 1, 2, 6, 7, S2, S3 | |
| WM 04.84 | 34 | Brazil | Clinical | 1986 | 1, 2, 6, 7, S2, S3 | |
| WM 05.274 | 29 | Colombia | Clinical | 2002 | 1, 2, 6, 7, S2, S3 | |
| WM 05.275 | 25 | Colombia | Clinical | 2001 | 1, 2, 6, 7, S2, S3 | |
| WM 05.339 | 43 | Colombia | Environmental | 2005 | 2, S2, S3 | |
| WM 05.342 | 25 | Colombia | Environmental | 2005 | 2, S2, S3 | |
| WM 05.419 | 39 | Brazil | Clinical | 1988 | 1, 2, 6, 7, S2, S3 | |
| WM 05.452 | 16 | Brazil | Clinical | 1995 | 1, 2, 6, 7, S2, S3 | |
| WM 05.456 | 17 | Brazil | Environmental | 1994 | 1, 2, 6, 7, S2, S3 | |
| WM 05.457 | 19 | Brazil | Clinical | 1995 | 2, S2, S3 | |
| WM 05.461 | 14 | Brazil | Clinical | 1997 | 2, S2, S3 | |
| WM 05.462 | 15 | Brazil | Clinical | 1997 | 1, 2, 6, 7, S2, S3 | |
| WM 05.525 | 41 | Brazil | Clinical | 1997 | 1, 2, 6, 7, S2, S3 | |
| WM 05.527 | 28 | Brazil | Clinical | 1997 | 1, 2, 6, 7, S2, S3 | |
| WM 05.528 | 40 | Brazil | Clinical | 2001 | 1, 2, 6, 7, S2, S3 | |
| WM 05.529 | 27 | Brazil | Clinical | 1997 | 1, 2, 6, 7, S2, S3 | |
| WM 05.530 | 13 | Brazil | Clinical | 1999 | 1, 2, 6, 7, S2, S3 | |
| WM 05.533 | 11 | Brazil | Clinical | 1997 | 1, 2, 6, 7, S2, S3 | |
| WM 05.536 | 9 | Brazil | Clinical | 1997 | 2, S2, S3 | |
| WM 05.545 | 24 | Brazil | Clinical | 2001 | 2, S2, S3 | |
| WM 05.546 | 23 | Brazil | Clinical | 2001 | 2, S2, S3 | |
| WM 05.547 | 22 | Brazil | Clinical | 2001 | 1, 2, 6, 7, S2, S3 | |
| WM 06.12 | 37 | Venezuela | Clinical | 1996 | 2, S2, S3 | |
| WM 08.309 | 48 | Australia | Veterinary | 1997 | 1, 2, 6, 7, S2, S3 | |
| WM 08.311 | 5 | Australia | Veterinary | 1996 | 1, 2, 6, 7, S2, S3 | |
| WM 09.94 | 38 | Australia | Veterinary | 2001 | 1, 2, 6, 7, S2, S3 | |
| WM 09.152 | 48 | Australia | Environmental | 2009 | 2, S2, S3 | |
| WM 11.65 | 33 | Australia | Veterinary | 2011 | 2, S2, S3 | |
| VGIII | WM 11.139 | 143 | USA | Veterinary | 2011 | 1, 7 |
| VGIV | WM 779 | 70 | South Africa | Veterinary | 1994 | 1, 7 |
| VNI | H99 | 2 | USA | Clinical | 1978 | 7 |
| VNIV | JEC21 | 126 | USA | Clinical | 1997 | 7 |
The strain designation, major molecular type, MLST sequence type, and figures that the strains are shown on are indicated.
FIG 6 fineStructure analysis of dominant VGII subtypes. To identify the population structure and possible recombination events within VGII, fineStructure analysis was performed using the SNP matrix developed for Fig. 2. Using one representative from each of the 32 VGII subtypes, whole-genome SNP data were reduced to a pairwise similarity matrix. The population structure is identified using this similarity matrix, where the underlying model assumes individuals within populations will share more regions of their genome with each other and have a similar amount of admixture with individuals from different populations. Identified populations are merged one at a time, at each step using the most likely population merge, to relate populations to each other through a tree. The x-axis analysis represents the strain as a “recipient,” and the y axis represents the strain as a “donor” of genomic regions. The scale bar represents the number of shared genome regions with blue being the greatest amount of sharing and yellow being the least. The PNW-associated subtype representatives are outlined in green.
BLAT score ratio gene content comparison
| Gene content similarity and is-cDNA | Family hit(s) | Pfam | E value(s) |
|---|---|---|---|
| Present in PNW VGIIa/c | |||
| is-cDNA 1 | Transmembrane amino acid transporter protein family | PF01490.13 | 1.90E−33 |
| is-cDNA 2 | Endoribonuclease L-PSP | PF01042.16 | 8.30E−39 |
| is-cDNA 3 | Aminotransferase class I and II domain | PF00155.16 | 5.20E−47 |
| is-cDNA 4 | No significant matches | ||
| is-cDNA 5 | Zinc finger double domain, fungus-specific transcription factor domain | PF13465.1, PF04082.13 | 4.4E−7, 2.3E−16 |
| is-cDNA 6 | Major facilitator superfamily | PF07690.11 | 5.80E−11 |
| is-cDNA 7 | Peptidase family M20/M25/M40, peptidase dimerization domain | PF01546.23, PF07687.9 | 3E−6, 4.2E−9 |
| is-cDNA 8 | Major facilitator superfamily, fungus-specific transcription factor domain | PF07690.11, PF04082.13 | 5.5E−29, 9.6E−12 |
| is-cDNA 9 | No significant matches | ||
| is-cDNA 10 | Arylsulfotransferase (ASST) family | PF14269.1 | 9.90E−14 |
| is-cDNA 11 | Major facilitator superfamily | PF07690.11 | 7.20E−23 |
| is-cDNA 12 | Phosphatidylethanolamine-binding protein domain | PF01161.15 | 5.70E−18 |
| is-cDNA 13 | Fungus-specific transcription factor domain | PF04082.13 | 2.90E−05 |
| is-cDNA 14 | Glycosyl hydrolase family 32 N-terminal domain, glycosyl hydrolase family 32 C-terminal domain | PF00251.15, PF08244.7 | 1.8E−51 4.8E−10 |
| is-cDNA 15 | No significant matches | ||
| is-cDNA 16 | Alcohol dehydrogenase GroES-like domain, zinc-binding dehydrogenase | PF08240.7, PF13602.1 | 8.5E−6, 2.8E−19 |
| is-cDNA 17 | No significant matches | ||
| Present in PNW VGIIb | |||
| is-cDNA 18 | E1-E2 ATPase, haloacid dehalogenase-like hydrolase | 3.6E−47, 3.1E−21 | |
| is-cDNA 19 | No significant matches | ||
| is-cDNA 20 | No significant matches | ||
| Present in PNW VGIIa | |||
| is-cDNA 21 | Sugar (and other) transporter | PF00083.19 | 1.20E−94 |
| is-cDNA 22 | Alcohol dehydrogenase GroES-like domain, zinc-binding dehydrogenase | PF08240.7, PF00107.21 | 1.6E−28, 1.6E−16 |
| is-cDNA 23 | Major facilitator superfamily | PF07690.11 | 1.20E−17 |
| is-cDNA 24 | No significant matches | ||
| is-cDNA 25 | Aldo/keto reductase family | PF00248.16 | 1.30E−52 |
| is-cDNA 26 | Protein of unknown function, putative collagen-binding domain of a collagenase | PF13204.1, PF12904.2 | 2.1E−54, 7.4E−19 |
| is-cDNA 27 | Sugar (and other) transporter | PF00083.19 | 3.70E−93 |
| is-cDNA 28 | Alcohol dehydrogenase GroES-like domain, zinc-binding dehydrogenase | PF08240.7, PF00107.21 | 5.3E−28, 1.2E−15 |
| is-cDNA 29 | Fungus-specific transcription factor domain, fungal Zn(2)-Cys(6) binuclear cluster domain | PF04082.13, PF00172.13 | 2E−16, 1.8E−4 |
| is-cDNA 30 | No significant matches | ||
| is-cDNA 31 | No significant matches | ||
| is-cDNA 32 | Aspartyl protease | PF09668.5 | 3.30E−05 |
| is-cDNA 33 | Helicase conserved C-terminal domain, DEAD/DEAH box helicase | PF00271.26, PF00270.24 | 4.6E−7, 1E−4 |
| Present in PNW VGIIc | |||
| is-cDNA 34 | Fungus-specific transcription factor domain | PF04082.13 | 2.50E−11 |
| is-cDNA 35 | Lyase, adenylosuccinate lyase C terminus | PF00206.15, PF10397.4 | 1.5E−47, 2.6E−18 |
| is-cDNA 36 | Sugar (and other) transporter | PF00083.19 | 5.40E−80 |
| is-cDNA 37 | No significant matches | ||
| is-cDNA 38 | No significant matches | ||
| is-cDNA 39 | Protein of unknown function | PF11175.3 | 1.40E−80 |
| is-cDNA 40 | Sugar (and other) transporter | PF00083.19 | 8.30E−63 |
| is-cDNA 41 | Protein of unknown function | PF11175.3 | 6.70E−83 |
| is-cDNA 42 | No significant matches | ||
| is-cDNA 43 | No significant matches | ||
| Present in PNW VGIIa/b/c and missing in half of VGII STs | |||
| is-cDNA 44 | Glycosyl hydrolase family 3 N-terminal domain, fibronectin type III-like domain | PF00933, PF14310 | 1.9E−70,7.5E−20 |
| is-cDNA 45 | Alpha- | PF08531, PF05592 | 04.7E−36, 9.5E−166 |
| is-cDNA 46 | Sugar (and other) transporter | PF00083 | 2.00E−57 |
| is-cDNA 47 | No significant matches | ||
| Missing in PNW and present in half of VGII STs | |||
| is-cDNA 48 | Fungus-specific transcription factor domain | PF04082.13 | 1.90E−23 |
| is-cDNA 49 | Proline dehydrogenase | PF01619.13 | 4.60E−31 |
| is-cDNA 50 | Transmembrane amino acid transporter protein | PF01490.13 | 2.8E−17, 1E−9 |
FIG 7 Population-level gene content analysis. To identify shared and differing gene content between and among the PNW subtypes compared to other VGII subtypes, other C. gattii molecular types, and other Cryptococcus species, BLAT score ratio analysis was performed, which is described in detail in the Materials and Methods. The genomes scored are the same as in Fig. 6 plus one representative each from VGI, VGIII, VGIV, C. neoformans var. neoformans, and C. neoformans var. grubii. VGII isolates are presented in the populations identified by fineStructure analysis where the tree on top is reproduced from Fig. 6. The rows on the left are divided by comparison group (VGIIa only, VGIIa and VGIIc only, etc.); these rows are further grouped by identified contiguous gene clusters (clusters 1 to 7). Genes of high homology between groups are yellow (complete homology = 1.0 on the heat map bar), and no homology (complete absence of the scored gene = 0.0) is represented by blue, with intermediate colors representing a gradient of similarity. The PNW population representatives and their scores are outlined in green.